Charles Schwab Investment Management Inc Vincerx Pharma, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-39,707 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$0.0 - $0.0 $0 - $0	8,506 Added 27.26%	39,707 $405,000
Q3 2021 Nov 16, 2021	BUY	$0.0 - $0.0 $0 - $0	13,999 Added 81.38%	31,201 $505,000
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $464,454	17,202 New	17,202 $224,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.